# Supernus Pharmaceuticals, Inc.: Form 8-K, filed May 6, 2025

- Company: [Supernus Pharmaceuticals, Inc.](/companies/supn.md) (CIK 1356576)
- Form: 8-K
- Filed: 2025-05-06
- Accepted by EDGAR: May 6, 2025, 16:14 ET
- Period: 2025-05-06
- Accession: 0001356576-25-000031
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1356576/000135657625000031/supn-20250506.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1356576/000135657625000031/

## Items reported

- Item 2.02: Results of operations

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1356576/000135657625000031/supn-20250506.htm

Filed May 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001356576-25-000031. Last ingested by Listed: Nov 4, 2026, 18:21 ET. No prices; not investment advice.